CNBX PHARMACEUTICALS INC. Proceeds from Sale of Debt Securities, Available-for-sale
CNBX PHARMACEUTICALS INC. (CNBX) reported Proceeds from Sale of Debt Securities, Available-for-sale of $0 for the 9-month period ending 2024-05-31, per its 10-Q filed 2024-07-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt · last filed 2024-07-15
- CNBX PHARMACEUTICALS INC. proceeds from sale of debt securities, available-for-sale for the quarter ending 2024-05-31 was $0.00.
- CNBX PHARMACEUTICALS INC. proceeds from sale of debt securities, available-for-sale for the quarter ending 2023-05-31 was $0.00.
- CNBX PHARMACEUTICALS INC. proceeds from sale of debt securities, available-for-sale for the quarter ending 2022-05-31 was $0.00.
| Period end | Proceeds from Sale of Debt Securities, Available-for-sale 3 month | Proceeds from Sale of Debt Securities, Available-for-sale 6 month | Proceeds from Sale of Debt Securities, Available-for-sale 9 month |
|---|---|---|---|
| 2024-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-07-15 | $0.00 10-Q · filed 2024-07-15 | |
| 2024-02-29 | $0.00 10-Q · filed 2024-04-16 | ||
| 2023-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-07-15 | $24.70K 10-Q · filed 2024-07-15 | |
| 2023-02-28 | $24.70K 10-Q · filed 2024-04-16 | ||
| 2022-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-07-14 | $0.00 10-Q · filed 2023-07-14 | |
| 2022-02-28 | $0.00 10-Q · filed 2023-04-14 |